|
PRRG4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.32630000041034E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.90220000000552E-05 |
| Normal-vs-Stage2 |
8.301500E-03 |
| Normal-vs-Stage3 |
1.06700000002125E-06 |
| Normal-vs-Stage4 |
1.22789999945638E-07 |
| Stage1-vs-Stage2 |
8.162800E-01 |
| Stage1-vs-Stage3 |
6.159800E-02 |
| Stage1-vs-Stage4 |
8.664100E-03 |
| Stage2-vs-Stage3 |
1.632400E-01 |
| Stage2-vs-Stage4 |
4.496400E-02 |
| Stage3-vs-Stage4 |
4.031200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.6327000003994E-07 |
| Normal-vs-AfricanAmerican |
4.0420000000374E-06 |
| Normal-vs-Asian |
9.174000E-02 |
| Caucasian-vs-AfricanAmerican |
9.516000E-02 |
| Caucasian-vs-Asian |
8.923000E-01 |
| AfricanAmerican-vs-Asian |
6.149400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.15110000315144E-08 |
| Normal-vs-Female |
2.433600E-04 |
| Male-vs-Female |
1.123190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.784340E-04 |
| Normal-vs-Age(41-60Yrs) |
1.67225999999632E-05 |
| Normal-vs-Age(61-80Yrs) |
4.00040000014812E-07 |
| Normal-vs-Age(81-100Yrs) |
8.837700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.146030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.091200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.490360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.274200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.208200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.278000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.416600E-01 |
| Normal-vs-Grade 2 |
3.364500E-04 |
| Normal-vs-Grade 3 |
5.35610000018671E-07 |
| Normal-vs-Grade 4 |
5.24609999885683E-09 |
| Grade 1-vs-Grade 2 |
6.408000E-01 |
| Grade 1-vs-Grade 3 |
2.415000E-01 |
| Grade 1-vs-Grade 4 |
2.628000E-02 |
| Grade 2-vs-Grade 3 |
4.067600E-02 |
| Grade 2-vs-Grade 4 |
2.217000E-04 |
| Grade 3-vs-Grade 4 |
2.967900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.403500E-02 |
| Normal-vs-ccB subtype |
4.25030011186323E-10 |
| ccA subtype-vs-ccB subtype |
2.33279995320856E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.2752999999941E-06 |
| Normal-vs-N1 |
1.281020E-03 |
| N0-vs-N1 |
2.398600E-01 |
|
|
